Properties (41)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:availableIn |
oral tablet
|
| gptkbp:canLeadTo |
HIV transmission
|
| gptkbp:contains |
emtricitabine
tenofovir disoproxil fumarate |
| gptkbp:contraindication |
severe renal impairment
|
| gptkbp:dosageForm |
once daily
|
| gptkbp:hasArea |
reduce HIV infection rates
|
| https://www.w3.org/2000/01/rdf-schema#label |
Truvada
|
| gptkbp:isAssociatedWith |
reduced viral load
|
| gptkbp:isAvailableIn |
various countries
|
| gptkbp:isConsidered |
effective when taken consistently
safe during pregnancy |
| gptkbp:isDiscussedIn |
medical guidelines
|
| gptkbp:isEvaluatedBy |
long-term safety
|
| gptkbp:isFocusedOn |
in itself
|
| gptkbp:isLinkedTo |
adherence_challenges
|
| gptkbp:isNear |
cure for HIV
|
| gptkbp:isPartOf |
combination therapy
HIV prevention programs HIV prevention toolkit |
| gptkbp:isRecognizedFor |
gptkb:CDC
HIV-negative individuals without risk factors people with active hepatitis B |
| gptkbp:isSubjectTo |
patent laws
|
| gptkbp:isUsedBy |
high-risk populations
|
| gptkbp:isUsedIn |
HIV prevention strategies
post-exposure prophylaxis (PEP) |
| gptkbp:lastProduced |
2004
|
| gptkbp:partOf |
HIV treatment regimen
PrEP regimen |
| gptkbp:producedBy |
gptkb:Gilead_Sciences
|
| gptkbp:requires |
kidney function
|
| gptkbp:research |
clinical trials
|
| gptkbp:sideEffect |
headache
nausea diarrhea |
| gptkbp:takesPlaceIn |
other antiretroviral drugs
|
| gptkbp:usedFor |
treatment of HIV infection
prevention of HIV infection |